
Azenta, Inc.
AZTANASDAQHealthcareMedical - Instruments & Supplies
Regular session
$33.6242
−$3.7758 · -10.10%
AZTA company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
47
Fair Value
Momentum
39
Weakening
Sentiment
54
Mixed
Risk resilience
45
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteAzenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- US
- CEO
- John Marotta
- Listed since
- Feb 2, 1995
- Employees
- 2,900
Market position
Day range
Current $33.6242
52-week range
Current $33.6242
- Open
- $33.32
- Previous close
- $37.40
- Volume
- 1.13M
- 1.19× average
- Average volume
- 948.23K
- Average daily volume
- Market cap
- 1.55B USD
- Beta
- 1.38
- Market reference 1
- 50-day average
- $27.8364
- +20.79% above average
- 200-day average
- $28.1887
- +19.28% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 1.15B USD
- P/E (TTM)
- -12.23×
- P/B (TTM)
- 1.01×
- P/S (TTM)
- 2.52×
- EV / EBITDA
- 21.18×
- Earnings yield
- -4.24%
- Free cash flow yield
- 2.92%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 44.05%
- Operating margin
- -3.49%
- Net margin
- -20.02%
- Return on equity
- -3.23%
- Return on assets
- -2.71%
- Return on invested capital
- 2.11%
Financial health
- Debt / equity
- 0.04×
- Current ratio
- 2.98×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 593.82M USD | 573.45M USD | 665.07M USD | 555.5M USD | 513.7M USD |
| Cost of goods sold | 323.54M USD | 318.83M USD | 431.82M USD | 324.88M USD | 299.19M USD |
| Gross profit | 270.28M USD | 254.62M USD | 233.26M USD | 230.62M USD | 214.51M USD |
| Research and development | 30.39M USD | 31.52M USD | 33.96M USD | 27.54M USD | 22.41M USD |
| Selling, general, and administrative | 251.16M USD | 253.08M USD | 281.5M USD | 227.1M USD | 188.5M USD |
| Operating expenses | 281.55M USD | 284.6M USD | 315.45M USD | 254.64M USD | 210.91M USD |
| Interest income | 18.78M USD | 33.18M USD | 43.74M USD | 20.29M USD | 632K USD |
| Interest expense | — | — | — | 4.59M USD | 2.04M USD |
| Depreciation and amortization | 61.21M USD | 90.74M USD | 85.58M USD | 53.7M USD | 56.87M USD |
| Operating income | −11.27M USD | −29.98M USD | −82.2M USD | −24.02M USD | 3.6M USD |
| Net income | −55.76M USD | −164.9M USD | −14.26M USD | −428.96M USD | 110.75M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 73%
- 8 beats, 3 misses, 0 met estimates
- Average EPS surprise
- +43.15%
- 11 comparable reports
- Latest EPS result
- 0.16
- Estimate 0.11 · Beat by 40.60%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
AZTA news
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
$0.40
2021 complete year0.0% since 2017
$0.40
2,017
$0.40
2,018
$0.40
2,019
$0.40
2,020
$0.40
2,021
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Dec 2, 2021 | $0.10Quarterly | Dec 3, 2021 | Dec 23, 2021 |
Dividend | Sep 2, 2021 | $0.10Quarterly | Sep 3, 2021 | Sep 24, 2021 |
Dividend | Jun 3, 2021 | $0.10Quarterly | Jun 4, 2021 | Jun 25, 2021 |
Dividend | Mar 4, 2021 | $0.10Quarterly | Mar 5, 2021 | Mar 26, 2021 |
Dividend | Dec 3, 2020 | $0.10Quarterly | Dec 4, 2020 | Dec 17, 2020 |
Dividend | Sep 3, 2020 | $0.10Quarterly | Sep 4, 2020 | Sep 25, 2020 |
Ex-dividend Dec 2, 2021
$0.10
Quarterly
Record Dec 3, 2021 · Payment Dec 23, 2021
Ex-dividend Sep 2, 2021
$0.10
Quarterly
Record Sep 3, 2021 · Payment Sep 24, 2021
Ex-dividend Jun 3, 2021
$0.10
Quarterly
Record Jun 4, 2021 · Payment Jun 25, 2021
Ex-dividend Mar 4, 2021
$0.10
Quarterly
Record Mar 5, 2021 · Payment Mar 26, 2021
Ex-dividend Dec 3, 2020
$0.10
Quarterly
Record Dec 4, 2020 · Payment Dec 17, 2020
Ex-dividend Sep 3, 2020
$0.10
Quarterly
Record Sep 4, 2020 · Payment Sep 25, 2020
AZTA peers
ETFs holding AZTA
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI37.18M0.00%2.3T USD0.03%$376.89-0.36%
Vanguard Morningstar Small-Cap ETFVB26.69M0.01%183.4B USD0.03%$302.25-0.82%
Vanguard Morningstar Small-Cap Value ETFVBR17.04M0.02%68.3B USD0.05%$247.86-0.53%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM14.24M0.08%17.03B USD0.03%$56.955-0.57%
Vanguard Extended Market ETFVXF13.26M0.01%93.7B USD0.05%$243.11-0.99%
Schwab U.S. Small-Cap ETFSCHA7.37M0.03%23.1B USD0.03%$34.395-1.26%
Dimensional - US Small Cap Value ETFDFSV6.77M0.08%8.42B USD0.30%$39.995-0.73%
Vanguard Russell 2000 ETFVTWO6.65M0.04%17.4B USD0.06%$120.33-0.76%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 37.18M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $376.89-0.36%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 26.69M
- Weight
- 0.01%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $302.25-0.82%
Vanguard Morningstar Small-Cap Value ETFVBR- Market value
- 17.04M
- Weight
- 0.02%
- AUM
- 68.3B USD
- Expense ratio
- 0.05%
- Price / 1D
- $247.86-0.53%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM- Market value
- 14.24M
- Weight
- 0.08%
- AUM
- 17.03B USD
- Expense ratio
- 0.03%
- Price / 1D
- $56.955-0.57%
Vanguard Extended Market ETFVXF- Market value
- 13.26M
- Weight
- 0.01%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $243.11-0.99%
Schwab U.S. Small-Cap ETFSCHA- Market value
- 7.37M
- Weight
- 0.03%
- AUM
- 23.1B USD
- Expense ratio
- 0.03%
- Price / 1D
- $34.395-1.26%
Dimensional - US Small Cap Value ETFDFSV- Market value
- 6.77M
- Weight
- 0.08%
- AUM
- 8.42B USD
- Expense ratio
- 0.30%
- Price / 1D
- $39.995-0.73%
Vanguard Russell 2000 ETFVTWO- Market value
- 6.65M
- Weight
- 0.04%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $120.33-0.76%
Continue in GoAI
Research AZTAresearch.disclaimer











